Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Metastatic Hormone-sensitive Prostate Cancer × darolutamide × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 8 Non-metastatic Castration-resistant Prostate Cancer 3 Urogenital Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Neoplasm Metastasis 1 Metastatic Hormone-sensitive Prostate Cancer 1 Fatigue 1 Depression 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Advanced Prostate Carcinoma 1

Interventions

enzalutamide 1 darolutamide 1 apalutamide 1 Docetaxel 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06498921 2024-10-24

BELBEQA

Bayer

Metastatic Hormone-sensitive Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡